Twin Tree Management, LP Summit Therapeutics Inc. Transaction History
Twin Tree Management, LP
- $22.8 Billion
- Q3 2025
A detailed history of Twin Tree Management, LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 27,300 shares of SMMT stock, worth $497,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,300
Previous 38,200
28.53%
Holding current value
$497,951
Previous $812,000
30.42%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
264Shares Held
94.3MCall Options Held
4.72MPut Options Held
4.03M-
Baker Bros. Advisors LP New York, NY33.7MShares$615 Million5.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$144 Million0.0% of portfolio
-
State Street Corp Boston, MA6.36MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.54MShares$82.8 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.67B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...